Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Ekso Bionics (NASDAQ:EKSO) in a report issued on Wednesday morning. The brokerage issued a hold rating on the stock.

Several other research firms have also recently weighed in on EKSO. HC Wainwright dropped their price objective on shares of Ekso Bionics from $10.00 to $9.00 and set a “buy” rating for the company in a research report on Tuesday, October 29th. Lake Street Capital cut their price target on Ekso Bionics from $2.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th.

Ekso Bionics Price Performance

Shares of EKSO stock opened at $0.66 on Wednesday. Ekso Bionics has a 52 week low of $0.66 and a 52 week high of $3.13. The stock has a market capitalization of $14.61 million, a PE ratio of -1.03 and a beta of 1.47. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.14 and a current ratio of 2.81. The stock’s fifty day moving average is $0.97 and its 200-day moving average is $1.08.

Ekso Bionics (NASDAQ:EKSO) last issued its quarterly earnings results on Monday, October 28th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.02). Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. The company had revenue of $4.13 million for the quarter, compared to analyst estimates of $6.00 million. During the same quarter last year, the company earned ($0.24) EPS. Equities research analysts expect that Ekso Bionics will post -0.48 EPS for the current fiscal year.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.